Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like ...

Nektar Therapeutics has completed target enrollment for its phase 2b study of rezpegaldesleukin for the treatment of patients ...

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

Perioral dermatitis is a rash that appears as clusters of inflamed skin and small raised bumps around the mouth and nose. The ...

As we increase the number of patients, we remain excited by the outlook for our Phase 1 clinical trial of soquelitinib for ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Progressing first-in-class, tissue-tethered autoimmune platform – Type 1 diabetes candidate on track for CTA submission in 2025; first universal candidate targeting CD1a initially for atopic ...

SAN CARLOS, CA and FORT WORTH, TX / / January 9, 2025 / CAGE Bio, Inc., a clinical-stage biotechnology company advancing ...

From atopic dermatitis to contact dermatitis, discover expert-backed treatments and lifestyle changes that can help manage ...

Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...